- Home
- TZUP vs ICCM Comparison
TZUP vs ICCM Comparison
Compare TZUP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZUP
- ICCM
- Stock Information
- Founded
- TZUP 2020
- ICCM 2006
- Country
- TZUP United States
- ICCM Israel
- Employees
- TZUP N/A
- ICCM N/A
- Industry
- TZUP
- ICCM
- Sector
- TZUP
- ICCM
- Exchange
- TZUP NYSE
- ICCM Nasdaq
- Market Cap
- TZUP 66.7M
- ICCM 59.9M
- IPO Year
- TZUP N/A
- ICCM N/A
- Fundamental
- Price
- TZUP $9.95
- ICCM $1.05
- Analyst Decision
- TZUP
- ICCM Strong Buy
- Analyst Count
- TZUP 0
- ICCM 1
- Target Price
- TZUP N/A
- ICCM $2.50
- AVG Volume (30 Days)
- TZUP 315.9K
- ICCM 347.5K
- Earning Date
- TZUP 08-11-2025
- ICCM 08-19-2025
- Dividend Yield
- TZUP N/A
- ICCM N/A
- EPS Growth
- TZUP N/A
- ICCM N/A
- EPS
- TZUP N/A
- ICCM N/A
- Revenue
- TZUP $487.00
- ICCM $3,273,000.00
- Revenue This Year
- TZUP N/A
- ICCM $83.41
- Revenue Next Year
- TZUP N/A
- ICCM $185.02
- P/E Ratio
- TZUP N/A
- ICCM N/A
- Revenue Growth
- TZUP N/A
- ICCM 0.34
- 52 Week Low
- TZUP $2.02
- ICCM $0.48
- 52 Week High
- TZUP $13.44
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- TZUP N/A
- ICCM 51.32
- Support Level
- TZUP N/A
- ICCM $0.96
- Resistance Level
- TZUP N/A
- ICCM $1.17
- Average True Range (ATR)
- TZUP 0.00
- ICCM 0.08
- MACD
- TZUP 0.00
- ICCM 0.01
- Stochastic Oscillator
- TZUP 0.00
- ICCM 63.89
About TZUP THUMZUP MEDIA CORP
Thumzup Media Corp operates in the social media branding and marketing industry. The company operates in a single business segment which is social media marketing. The Thumzup App works on both iPhone and Android mobile operating systems and connects brands and people who use and love these brands. The easy-to-use dashboard allows advertisers to programmatically customize their campaigns. Cash payments are made to App users/creators through Venmo and PayPal.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.